EAGLE PHARMACEUTICALS, INC. Insider Trading for January 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in EAGLE PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in EAGLE PHARMACEUTICALS, INC. for January 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 0.00 | 189,000 | 0 | 189,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Tarriff Scott | CEO | Option Exercise | A | 59.14 | 157,000 | 9,284,980 | 157,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | RATOFF STEVEN B | Director | Option Exercise | A | 59.14 | 10,000 | 591,400 | 10,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Option Exercise | A | 0.00 | 30,000 | 0 | 30,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Option Exercise | A | 59.14 | 50,000 | 2,957,000 | 50,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Pernock David | Pres. & Chief Comm. ... | Grant | A | 0.00 | 10,000 | 0 | 10,966 | 966 to 11 K (+1,035.20 %) |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 0.00 | 21,000 | 0 | 21,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Option Exercise | A | 59.14 | 37,000 | 2,188,180 | 37,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Meyers Pete A. | Chief Financial Off ... | Grant | A | 0.00 | 7,000 | 0 | 7,700 | 700 to 7.7 K (+1,000.00 %) |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | A | 0.00 | 9,000 | 0 | 9,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Option Exercise | A | 59.14 | 15,000 | 887,100 | 15,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Krill Steven L. | EVP & Chief Scienti ... | Grant | A | 0.00 | 3,000 | 0 | 3,000 | 0 to 3 K |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Option Exercise | A | 0.00 | 27,000 | 0 | 27,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Option Exercise | A | 59.14 | 43,000 | 2,543,020 | 43,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Hepner Adrian | EVP and Chief Medic ... | Grant | A | 0.00 | 9,000 | 0 | 9,000 | 0 to 9 K |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Graves Michael | Director | Option Exercise | A | 59.14 | 10,000 | 591,400 | 10,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Glenning Robert | Director | Option Exercise | A | 59.14 | 10,000 | 591,400 | 10,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | FLAUM SANDER A | Director | Option Exercise | A | 59.14 | 10,000 | 591,400 | 10,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Edlin Richard A. | Director | Option Exercise | A | 59.14 | 10,000 | 591,400 | 10,000 | |
Jan 09 2018 | EGRX | EAGLE PHARMACEUTIC ... | Braunstein Douglas L | Director | Option Exercise | A | 59.14 | 10,000 | 591,400 | 10,000 |